Progyny, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-12-31 was 1.57M shares.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 265.48K shares, a 49.93% decline from fiscal 2024.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 530.26K shares, a 78.30% decline from fiscal 2023.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 2.44M shares, a 21.32% increase from fiscal 2022.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 2.01M shares, a 41.45% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 265.48K shares 10-K · filed 2026-02-27 | |
| 2024-12-31 | 530.26K shares 10-K · filed 2025-03-03 | |
| 2023-12-31 | 2.44M shares 10-K · filed 2024-02-29 | |
| 2022-12-31 | 2.01M shares 10-K · filed 2023-03-01 | |
| 2021-12-31 | 3.44M shares 10-K · filed 2022-03-01 | |
| 2020-12-31 | 2.98M shares 10-K · filed 2021-03-01 | |
| 2019-12-31 | 1.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 6.49M shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |